Silent hypoxia in COVID-19: pathomechanism and possible management strategy

The novel coronavirus disease 2019 (COVID-19) has become a severe health issue, especially to the patients who develop silent hypoxia condition after SARS-CoV-2 infection. Due to the lack of dyspnoea and extremely low oxygen saturation level, these patients are at exceptionally higher risk. Although...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Ahsab, Tabassum, Tahani, Araf, Yusha, Al Nahid, Abdullah, Ullah, Md. Asad, Hosen, Mohammad Jakir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Mini Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062941/
https://www.ncbi.nlm.nih.gov/pubmed/33891272
http://dx.doi.org/10.1007/s11033-021-06358-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062941/
https://www.ncbi.nlm.nih.gov/pubmed/33891272
http://dx.doi.org/10.1007/s11033-021-06358-1

Ejemplares similares